Effects of different 1-34 parathyroid hormone dosages on fibroblast growth factor-23 secretion in human bone marrow cells following osteogenic differentiation
The importance of fibroblast growth factor (FGF)-23 as part of a hormonal bone-kidney-axis has been well established. Lately, FGF-23 has been suggested as an independent risk factor of death in patients on chronic hemodialysis. Hyperparathyroidism is a common feature of advanced kidney failure or en...
Main Authors: | Frank-Peter Tillmann, Daniela Hofen, Monika Herten, Rüdiger Krauspe, Marcus Jäger |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2014-06-01
|
Series: | Orthopedic Reviews |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/or/article/view/5314 |
Similar Items
-
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
by: Cheng Q, et al.
Published: (2018-11-01) -
Experience with a third-generation parathyroid hormone assay (BIO-PTH) in the diagnosis of primary hyperparathyroidism in a Brazilian population
by: Teresa Cristina P. Bonanséa, et al.
Published: (2016-08-01) -
Fibroblast growth factor-23 and Klotho in bone/mineral and parathyroid disorders
by: Krajisnik, Tijana
Published: (2009) -
Study of PTH-FNAB of the Parathyroid Glands as a Method of Topical Diagnosis in Primary Hyperparathyroidism
by: I V Kim, et al.
Published: (2014-06-01) -
Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements
by: M.N. Ohe, et al.
Published: (2003-06-01)